Growth Metrics

Conmed (CNMD) Receivables - Net (2016 - 2025)

Conmed (CNMD) has disclosed Receivables - Net for 16 consecutive years, with $247.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 4.25% year-over-year to $247.8 million, compared with a TTM value of $247.8 million through Dec 2025, up 4.25%, and an annual FY2025 reading of $247.8 million, up 4.25% over the prior year.
  • Receivables - Net was $247.8 million for Q4 2025 at Conmed, up from $224.9 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $247.8 million in Q4 2025 and bottomed at $164.0 million in Q1 2021.
  • Average Receivables - Net over 5 years is $212.4 million, with a median of $223.0 million recorded in 2025.
  • The sharpest move saw Receivables - Net rose 26.62% in 2023, then decreased 8.42% in 2025.
  • Year by year, Receivables - Net stood at $183.9 million in 2021, then grew by 4.06% to $191.3 million in 2022, then rose by 26.62% to $242.3 million in 2023, then decreased by 1.88% to $237.7 million in 2024, then increased by 4.25% to $247.8 million in 2025.
  • Business Quant data shows Receivables - Net for CNMD at $247.8 million in Q4 2025, $224.9 million in Q3 2025, and $234.1 million in Q2 2025.